Table 1.
Outcome | Corresponding secondary objective | Datasets analysed | |
Primary care | Secondary care | ||
Health conditions and symptoms in children | 1. | ||
Other allergic and allergy-related conditions: | 1.a | ||
|
x | ||
|
x | ||
|
x | ||
|
x | ||
|
x | x | |
|
x | ||
Autoimmune diseases: | 1.b | ||
|
x | x | |
|
x | x | |
|
x | x | |
|
x | x | |
|
x | x | |
|
x | x | |
|
x | x | |
|
x | x | |
|
x | ||
Infections and inflammation: | 1 .c | ||
|
x | ||
|
x | ||
|
x | ||
|
x | ||
|
x | x | |
|
x | x | |
|
x | x | |
|
x | x | |
|
x | x | |
|
x | ||
Other immune system-related conditions: | 1.d | ||
|
x | ||
|
x | x | |
Neurodevelopmental conditions: | 1.e | ||
|
x | ||
|
x | ||
|
x | ||
Less specific measures of child health: | 1 .f | ||
|
x | ||
|
x | ||
Healthcare utilisation in children | 2. | ||
|
x | ||
|
x | ||
Maternal outcomes (6 weeks post partum) | 3. | ||
|
x | x | |
|
x | x | |
|
x | x | |
|
x | x | |
|
x | x | |
|
x | x | |
|
x | ||
|
x | ||
|
x |
*Exploratory outcome due to insufficient evidence base, including lack of longitudinal studies investigating the association between microbiota/early antibiotic exposure and outcome of interest;
†Tabulation if the outcome is very rare.
ADHD, attention deficit hyperactivity disorder; ITP, thrombocytopenic purpura; SLE, systemic lupus erythematosus.